Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00052078
Status:
COMPLETED
Last Update Posted:
2017-09-19
First Post:
2003-01-22
Brief Title:
Child and Adolescent Anxiety Disorders CAMS
Sponsor:
Johns Hopkins University
Organization:
Johns Hopkins University
Study Overview
Official Title:
ChildAdolescent Anxiety Multimodal Treatment Study
Status:
COMPLETED
Status Verified Date:
2017-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This randomized controlled trial compared the efficacy of the medication sertraline Zoloft cognitive-behavioral therapy the combination of these treatments and placebo for youth with anxiety disorders
Detailed Description:
Anxiety disorders are among the most common conditions affecting children and adolescents These disorders impair school social and family functioning When left untreated they also put children at risk for major depression and substance abuse in late adolescence and adulthood Previous studies demonstrated the efficacy of cognitive behavioral therapy and selective serotonin-reuptake inhibitors for the treatment of child anxiety disorders This study is testing the relative and combined efficacy of cognitive behavioral therapy and selective serotonin reuptake inhibitors as compared to each other and pill placebo
During Phase I of this two-phase study 488 participants were randomly assigned to receive sertraline Zoloft cognitive behavioral therapy a combination of these treatments or a placebo for 12 weeks Phase II involved a 6-month maintenance period for participants
During Phase I of this two-phase study 488 participants were randomly assigned to receive sertraline Zoloft cognitive behavioral therapy a combination of these treatments or a placebo for 12 weeks Phase II involved a 6-month maintenance period for participants
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| DSIR 84-CTP | US NIH GrantContract | None | httpsreporternihgovquickSearchU01MH064089 |
| U01MH064089 | NIH | None | None |